IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Locally Advanced Pancreatic Adenocarcinoma
OHSU Knight Cancer Institutemonoclonal_antibodyPhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 81/ 100
Competitive context
26 Active assets in the Locally Advanced Pancreatic Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Gdc-0449 OHSU Knight Cancer Institute | Phase 2 | B |
PANITUMUMAB SWOG Cancer Research Network | Phase 3 | B |
Sargramostim Barbara Ann Karmanos Cancer Institute | Phase 1/2 | B |
Regorafenib OHSU Knight Cancer Institute | Phase 2 | B |
Inno-206 OHSU Knight Cancer Institute | Phase 2 | B |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →